Patent ID: 11964943
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 0:
1. A compound, comprising Formula I:, or a pharmaceutically acceptable salt, solvate, radiolabeled form, stereoisomeric form, racemic mixture, geometric isomer, and/or tautomer thereof, wherein:
R is —(C6-C14)aryl, which is unsubstituted or substituted with 1, 2, 3, 4, or 5 independently selected R6 groups;
R6 is selected from:
(a) —H, —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, —(C1-C6)alkoxy, and —(C3-C5)cycloalkyl; and
(b) -halo, —C(halo)3, —CH(halo)2, —CH2(halo), —CN, —NO, —NO2, —N3, —OH, —SH, —N(R7)2, —NH(OH), —C(═O)R7, —C(═O)OR7, —OC(═O)R7, —C(═O)N(R7)2, —N(R7)C(═O)R7, —N(R7)C(═O)N(R7)2, —OC(═O)N(R7)2, and —N(R7)C(═O)OR7;

R1, R2, R4, and R5 are independently selected from:
(a) —H, —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, and —(C1-C6)alkoxy; and
(b) -halo, —C(halo)3, —CH(halo)2, —CH2(halo), —CN, —NO, —NO2, —N3, —OH, —SH, —N(R7)2, —NH(OH), —C(═O)R7, —C(═O)OR7, —OC(═O)R7, —C(═O)N(R7)2, —N(R7)C(═O)R7, —N(R7)C(═O)N(R7)2, —OC(═O)N(R7)2, and —N(R7)C(═O)OR7;

R3 is selected from the group consisting of:
(a) —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, and —(C1-C6)alkoxy; and
(b) -halo, —C(halo)3, —CH(halo)2, —CH2(halo), —CN, —NO, —NO2, —N3, —OH, —SH, —N(R7)2, —NH(OH), —C(═O)R7, —C(═O)OR7, —OC(═O)R7, —C(═O)N(R7)2, —N(R7)C(═O)R7, —N(R7)C(═O)N(R7)2, —OC(═O)N(R7)2, and —N(R7)C(═O)OR7;

each R7 is independently selected from the group consisting of —H, —(C1-C6)alkyl, —(C2-C6)alkenyl, and —(C2-C6)alkynyl; and
each halo is independently —F, —Cl, —Br, or —I.